Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07409337 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Aug 15, 2026 → Dec 15, 2026
See other at-risk trials from Nigde Omer Halisdemir University

Record History

  1. Primary and study completion pushed from Aug 15, 2026 to Dec 15, 2026v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized, sham-controlled trial aims to evaluate the effects of self-administered acupressure on menstrual pain severity and premenstrual symptoms in women aged 18-30 years with primary dysmenorrhea. Participants will be randomly assigned to either a self-acupressure intervention group or a sham self-acupressure control group. The intervention will be applied during the premenstrual and menstrual periods over approximately six months. The primary outcome is the change in menstrual pain severity, and secondary outcomes include changes in premenstrual symptom severity, analgesic use, and menstruation-related activity limitation.
Trial Details
NCT Number NCT07409337
Lead Sponsor Nigde Omer Halisdemir University
Conditions
(from sponsor)		 Primary Dysmenorrhea, Premenstrual Syndrome, Menstrual Pain
Related terms Dysmenorrhea, Premenstrual Syndrome
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov